Inhibiting NLRP3 with MCC950 has been shown to suppress myocardial-infarction-induced inflammasome activation, consequently ameliorating cardiac inflammation and fibrosis, and enhancing cardiac function [33]. This evidence concerns the gene NLRP3 and myocardial infarction.